{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:30:20Z","timestamp":1789576220221,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172203"],"award-info":[{"award-number":["82172203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112762","type":"journal-article","created":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T02:47:39Z","timestamp":1722134859000},"page":"112762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature"],"prefix":"10.1016","volume":"139","author":[{"given":"Yiming","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8320-1208","authenticated-orcid":false,"given":"Rui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.112762_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdermsci.2020.03.003","article-title":"Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism","volume":"98","author":"Murakami","year":"2020","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.112762_b0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-020-00503-5","article-title":"Palmoplantar pustulosis: Recent advances in etiopathogenesis and emerging treatments","volume":"21","author":"Misiak-Galazka","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112762_b0015","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/jdv.12272","article-title":"Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial","volume":"28","author":"Bissonnette","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112762_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jdermsci.2016.09.019","article-title":"Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway","volume":"85","author":"Bissonnette","year":"2017","journal-title":"J. Dermatol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2024.112762_b0025","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","article-title":"Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study","volume":"80","author":"Mrowietz","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112762_b0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2022.05.047","article-title":"Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting","volume":"87","author":"Reolid","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112762_b0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2022.04.027","article-title":"Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis","volume":"150","author":"McCluskey","year":"2022","journal-title":"J. Aller. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112762_b0040","first-page":"318","article-title":"The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112762_b0045","doi-asserted-by":"crossref","unstructured":"Xu Q, Wang X, Yang A, Wei G. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series. Infect Drug Resist. 2023;16:5165-5172. Published 2023 Aug 9. doi:10.2147\/IDR.S421299.","DOI":"10.2147\/IDR.S421299"},{"issue":"4","key":"10.1016\/j.intimp.2024.112762_b0050","doi-asserted-by":"crossref","first-page":"e13753","DOI":"10.1111\/dth.13753","article-title":"Successful therapy of palmoplantar pustulosis with tofacitinib-Report on three cases","volume":"33","author":"M\u00f6ssner","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.intimp.2024.112762_b0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clim.2016.10.003","article-title":"Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation","volume":"173","author":"Koga","year":"2016","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112762_b0060","first-page":"1387","article-title":"Response of palmoplantar pustulosis to upadacitinib: A case series of five patients","volume":"21","author":"Rahbar Kooybaran","year":"2023","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.intimp.2024.112762_b0065","doi-asserted-by":"crossref","unstructured":"Bissonnette R, Su\u00e1rez-Fari\u00f1as M, Li X, et al. Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris published correction appears in PLoS One. 2016;11(6):e0158190]. PLoS One. 2016;11(5):e0155215. doi:10.1371\/journal.pone.0155215.","DOI":"10.1371\/journal.pone.0158190"},{"key":"10.1016\/j.intimp.2024.112762_b0070","doi-asserted-by":"crossref","unstructured":"M, Ohtake T, Horibe Y, et al. Acrosyringium is the main site of the vesicle\/pustule formation in palmoplantar pustulosis. J Invest Dermatol. 2010;130(8):2010-2016. doi:10.1038\/jid.2010.87.","DOI":"10.1038\/jid.2010.87"},{"key":"10.1016\/j.intimp.2024.112762_b0075","doi-asserted-by":"crossref","unstructured":"Murakami M, Kaneko T, Nakatsuji T, et al. Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis. PLoS One. 2014;9(10):e110677. Published 2014 Oct 16. doi:10.1371\/journal.pone.0110677.","DOI":"10.1371\/journal.pone.0110677"},{"key":"10.1016\/j.intimp.2024.112762_b0080","doi-asserted-by":"crossref","unstructured":"M, Hagforsen E, Morhenn V, Ishida-Yamamoto A, Iizuka H. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum. Exp Dermatol. 2011;20(10):845-847. doi:10.1111\/j.1600-0625.2011.01325.","DOI":"10.1111\/j.1600-0625.2011.01325.x"},{"issue":"1","key":"10.1016\/j.intimp.2024.112762_b0085","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/ajd.13117","article-title":"Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report","volume":"61","author":"Haynes","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.intimp.2024.112762_b0090","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.2147\/CCID.S430156","article-title":"Secukinumab-induced alopecia areata successfully treated with tofacitinib in a patient with palmoplantar pustulosis","volume":"16","author":"Zhang","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112762_b0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jdcr.2019.12.006","article-title":"Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case","volume":"6","author":"Wang","year":"2020","journal-title":"JAAD Case Rep."},{"issue":"25","key":"10.1016\/j.intimp.2024.112762_b0100","doi-asserted-by":"crossref","first-page":"e11149","DOI":"10.1097\/MD.0000000000011149","article-title":"Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"19","key":"10.1016\/j.intimp.2024.112762_b0105","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.12998\/wjcc.v8.i19.4527","article-title":"Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report","volume":"8","author":"Li","year":"2020","journal-title":"World J. Clin. Cases"},{"issue":"13","key":"10.1016\/j.intimp.2024.112762_b0110","article-title":"SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: A case report","volume":"25","author":"Yuan","year":"2022","journal-title":"Front. Immunol."},{"issue":"06","key":"10.1016\/j.intimp.2024.112762_b0115","first-page":"397","article-title":"Three cases with palmoplantar pustulosis successfully treated by tofacitinib","volume":"39","author":"Wang","year":"2023","journal-title":"China J. Leprosy Skin Diseases"},{"issue":"1","key":"10.1016\/j.intimp.2024.112762_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamadermatol.2020.3095","article-title":"Tofacitinib for the treatment of nail lesions and palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome","volume":"157","author":"Li","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112762_b0125","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2020-217250","article-title":"Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: A pilot study with clinical and MRI evaluation","volume":"79","author":"Li","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112762_b0130","doi-asserted-by":"crossref","first-page":"2193662","DOI":"10.1080\/09546634.2023.2193662","article-title":"Secukinumab-induced paradoxical skin lesions, but successful treatment with tofacitinib in SAPHO syndrome: a case report","volume":"34","author":"Luana","year":"2023","journal-title":"J. Dermatolog. Treat."},{"issue":"3","key":"10.1016\/j.intimp.2024.112762_b0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000087019","article-title":"Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantaris","volume":"211","author":"Ozawa","year":"2005","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.intimp.2024.112762_b0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ced.13689","article-title":"Interleukin (IL)-8 and IL-36\u03b3 but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis","volume":"44","author":"Xiaoling","year":"2019","journal-title":"Clin. Exp. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T08:08:46Z","timestamp":1732954126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924012839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"alternative-id":["S1567576924012839"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112762","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112762"}}